Sign in to view content

Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK

Video
Published 2024

Author: Christiana Dinah, BSc, MBBS, MRes

Related

Baseline Characteristics of Patients Who Did or Did Not Maintain 12-Week and 16-Week Aflibercept 8 mg Dosing Intervals in the Phase 2/3 PHOTON Trial
Eric W Schneider, MD
Annual Meeting Talks
2023
Suprachoroidal Delivery of RGX-314 Gene Therapy for Diabetic Retinopathy The Phase II ALTITUDE Study
Dilsher S. Dhoot, MD
Annual Meeting Talks
2023
Endophthalmitis Rates After Bilateral Same Day Intravitreal Anti-VEGF Injections
Durga Borkar, MD
Updates from the Field
2018

Category: Retinal Vascular Disease

See more

Annual Meeting Talks